Goodwin

Mylan, Apotex, Coherus, and Adello File Amicus Briefs in Sandoz v. Amgen

As we covered in previous posts, the Supreme Court will hear arguments regarding the Federal Circuit’s interpretation of the BPCIA’s notice of commercial marketing requirement and patent dance provisions in April 2017. Several…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

Pharmaceutical Care Management Association, National Association of Chain Drug Stores, and Healthcare Supply Chain Association file Amicus Brief in Sandoz v. Amgen

As we have previously reported, in April the Supreme Court will hear arguments regarding the Federal Circuit’s interpretation of the BPCIA’s notice of commercial marketing requirement and patent dance provisions. As we reported…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

DC Court of Appeals Orders Rehearing of PHH v. CFPB

On February 16, 2017, the United States Court of Appeals for the DC Circuit granted Respondent Consumer Financial Protection Bureau’s (CFPB) petition for rehearing en banc of PHH Corp. v. CFPB, No. 15-1177 (D.C. Cir.). In doing…more
| Administrative Law, Civil Procedure, Constitutional Law, Consumer Protection, Finance & Banking

Genentech Requests Expedited Resolution of Patent Dance Dispute Against Amgen

As we previously reported, Genentech filed a complaint against Amgen in the District of Delaware seeking declaratory judgment that Amgen has violated the patent dance provisions of the BPCIA in connection with its proposed…more
|

AARP, AHIP, and Others File Amicus Briefs in Sandoz v. Amgen

As we have previously reported, the Supreme Court will next month hear arguments in Sandoz v. Amgen regarding the Federal Circuit’s interpretation of the BPCIA’s notice of commercial marketing requirement and patent dance…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

Celltrion Files Petition for IPR of Genentech’s Trastuzumab Patent

Celltrion has filed a petition for inter partes review (IPR2017-00959) of Genentech’s U.S. Patent 8,591,897. According to the petition, the patent is directed to methods of treating a sub-type of breast cancer with a regimen…more
| Intellectual Property, Science, Computers, & Technology

Celltrion Healthcare and Pfizer Present Data on Infliximab Trial

As we reported last November, the NOR-SWITCH Phase IV study concluded that patients could be safely and effectively switched from originator infliximab (Remicade®) to Celltrion’s biosimilar product CT-P13 (Remsima®). On…more
| Health, Science, Computers, & Technology

PTAB Denies Institution of IPR on Genentech’s Protein Folding Patent

The PTAB has denied institution of IPR2016-01608, in which Bioeq IP AG sought review of Genentech’s U.S. Patent 6,716,602. That patent is directed to methods for increasing the yield of a heterologous recombinant protein…more
| Intellectual Property, Science, Computers, & Technology

Biosimilars Council Files Amicus Brief in Sandoz v. Amgen

As we covered in a previous post, in April the Supreme Court will hear arguments regarding the BPCIA’s notice of commercial marketing requirement and patent dance provisions. Last week, the Biosimilars Council filed an amicus…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

Issue Two: Keeping Tabs on the PTAB

The availability of post-grant proceedings at the Patent Trial and Appeal Board (PTAB) has changed the face of patent litigation. This monthly digest is designed to keep you up-to-date by highlighting interesting PTAB, district…more
| Civil Procedure, Constitutional Law, Intellectual Property, Science, Computers, & Technology

Upcoming Oral Arguments in BPCIA Litigation

On Friday, the United States Supreme Court set oral arguments in Amgen v. Sandoz for April 26, 2017. Today, the United States Court of Appeals for the Federal Circuit announced that oral arguments in Amgen v. Hospira will…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

United States Amicus Brief Filed in Sandoz v. Amgen

Last week the Office of the Solicitor General (“SG”) filed an amicus brief on behalf of the United States in support of Sandoz’s position with respect to the BPCIA’s notice of commercial marketing requirement and patent dance…more
| Civil Procedure, Intellectual Property, Science, Computers, & Technology

Mortgage Servicer Enters in to $225 Million Consent Order with California DBO

On February 17, 2017, the California Department of Business Oversight (California DBO) announced that it had entered in to a $225 million consent order with a national mortgage servicer following an investigation by a…more
| Consumer Protection, Finance & Banking

Is a Bitcoin ETF Destined For Failure?

For the last three and a half years, the Securities and Exchange Commission (“SEC”) has been considering whether to approve placement of the Winklevoss bitcoin ETF (“COIN”) on the Bats exchange. However, the SEC’s inaction will…more
| Business Organizations, Finance & Banking, Securities Law

Northern District of Illinois Strikes TCPA Class Allegations

Earlier this month, the Northern District of Illinois struck the class allegations in Cholly v. Uptain Group, Inc., a single-count TCPA case filed against a medical services provider and a debt collector based on allegedly…more
| Civil Procedure, Communications & Media Law, Finance & Banking
Showing 1-15 of 1471 Results
|
View per page
Page: of 99
Contact

100 Northern Avenue
Boston, MA 02210, United States

  • 617.570.1000
  • 617.523.1231

Areas of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys

800+ Attorneys

This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×